Groupe Nature acquires Winco
Groupe Nature has signed an agreement with Nicolas Watine, founder and CEO of Winco, to acquire his stake in the comany. It specializes in the distribution of health and cosmetic products in parapharmacies affiliated to supermarket chains. This acquisition strengthens Groupe Nature’s position as a multi-channel specialist in the distribution of organic health products.
Founded in 1997, Groupe Nature distributes organic health products, mainly food supplements and cosmetics, through organic specialty shops, pharmacies and online.
Also founded in 1997, Winco is a reference distributor in the French parapharmacy market.
Oaklins’ team in France advised Groupe Nature on the acquisition of Winco.
Laurent Ducrocq
CEO, Groupe Nature
Talk to the deal team
Related deals
Nuzoa has acquired Dinazoo
Spanish private equity-backed Nuzoa, a prominent animal health distributor in Spain, has acquired Dinazoo. This acquisition marks one of the first steps in Nuzoa’s international expansion. It will strengthen Nuzoa’s relationships with key clients who also operate in the Portuguese market, along with its suppliers. This agreement will enhance both companies’ presence in the Portuguese market by gaining access to more advanced technology and expanding their portfolio in key areas of the business.
Learn moreNuzoa has acquired Siloal
Spanish private equity-backed Nuzoa, a prominent animal health distributor in Spain, has acquired Siloal. This acquisition marks one of the first steps in Nuzoa’s international expansion. It will strengthen Nuzoa’s relationships with key clients who also operate in the Portuguese market, along with its suppliers. This agreement will enhance both companies’ presence in the Portuguese market by gaining access to more advanced technology and expanding their portfolio in key areas of the business.
Learn moreVivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
Learn more